BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22589272)

  • 1. Identification of serum biomarker signatures associated with pancreatic cancer.
    Wingren C; Sandström A; Segersvärd R; Carlsson A; Andersson R; Löhr M; Borrebaeck CA
    Cancer Res; 2012 May; 72(10):2481-90. PubMed ID: 22589272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
    Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
    Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
    Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
    Xue A; Gandy RC; Chung L; Baxter RC; Smith RC
    Pancreatology; 2012; 12(2):124-9. PubMed ID: 22487522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.
    Liao WC; Wu MS; Wang HP; Tien YW; Lin JT
    Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
    Mroczko B; Lukaszewicz-Zajac M; Wereszczynska-Siemiatkowska U; Groblewska M; Gryko M; Kedra B; Jurkowska G; Szmitkowski M
    Pancreas; 2009 Aug; 38(6):613-8. PubMed ID: 19629003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible detection of pancreatic cancer by plasma protein profiling.
    Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; Kikuchi S; Endo M; Tsuchida A; Aoki T; Itoi T; Moriyasu F; Hirohashi S; Yamada T
    Cancer Res; 2005 Nov; 65(22):10613-22. PubMed ID: 16288055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein?
    Meggiato T; Basso D; Fabris C; Fogar P; Panozzo MP; Plebani M; Faggian D; Scalon P; Ferrara C; Del Favero G
    Dis Markers; 1990; 8(4):171-7. PubMed ID: 1708317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of B cell-activating factor in autoimmune pancreatitis.
    Yamanishi H; Kumagi T; Yokota T; Azemoto N; Koizumi M; Kobayashi Y; Abe M; Murakami H; Hiasa Y; Matsuura B; Kawamoto H; Yamamoto K; Onji M
    Pancreas; 2011 Aug; 40(6):840-5. PubMed ID: 21747319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms.
    Pezzilli R; Barassi A; Corsi MM; Morselli-Labate AM; Campana D; Casadei R; Santini D; Corinaldesi R; D'Eril GM
    Scand J Gastroenterol; 2010; 45(1):93-9. PubMed ID: 19883273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
    Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
    Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of serum CEACAM1 in patients with pancreatic cancer].
    Gong DY; Fu HX; Peng Y; You YQ; Li ZP
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):164-6. PubMed ID: 21269981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation profile of circulating plasma DNA in patients with pancreatic cancer.
    Melnikov AA; Scholtens D; Talamonti MS; Bentrem DJ; Levenson VV
    J Surg Oncol; 2009 Feb; 99(2):119-22. PubMed ID: 19065635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
    Liggett T; Melnikov A; Yi QL; Replogle C; Brand R; Kaul K; Talamonti M; Abrams RA; Levenson V
    Cancer; 2010 Apr; 116(7):1674-80. PubMed ID: 20143430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitis.
    Piecuch J; Rudzki M; Orkisz W; Swietochowska E; Wielkoszyński T; Waniczek D; Arendt J; Sosada K; Zurawiński W; Ładny JR
    Hepatogastroenterology; 2008; 55(81):258-61. PubMed ID: 18507120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.